Cognition Therapeutics Stock (NASDAQ: CGTX) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 1.98K / 149.14K |
Day Range | - - - |
52 Wk Range | 0.90 - 2.95 |
Market Cap | $71.70M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 44 |
Short Interest | 0.75% |
Days to Cover | 1.63 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Cognition Therapeutics (NASDAQ:CGTX) through any online brokerage.
Other companies in Cognition Therapeutics’s space includes: Universe Pharmaceuticals (NASDAQ:UPC), SCYNEXIS (NASDAQ:SCYX), CalciMedica (NASDAQ:CALC), Ocuphire Pharma (NASDAQ:OCUP) and Rani Therapeutics Hldgs (NASDAQ:RANI).
There is no analysis for Cognition Therapeutics.
Cognition Therapeutics has a consensus price target of $9.57.
The stock price for Cognition Therapeutics (NASDAQ: CGTX) is $1.79 last updated Today at July 24, 2024 at 8:29 AM EDT.
There are no upcoming dividends for Cognition Therapeutics.
Cognition Therapeutics’s Q2 earnings are confirmed for Tuesday, August 6, 2024.
There is no upcoming split for Cognition Therapeutics.
Cognition Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.